Literature DB >> 16783116

Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option.

Karen Cox1, Eleanor Wilson, Lesley Heath, Jacqueline Collier, Linda Jones, Ian Johnston.   

Abstract

Pressure on lung cancer clinics is increasing with the "2-week wait" initiative. This initiative is one of the key targets set out in the National Health Service (NHS) Cancer Plan for the United Kingdom, whereby all patients presenting with symptoms which may be indicative of a cancer diagnosis will be seen by a consultant within 2 weeks of initial presentation at their primary care provider. This has resulted in busy clinics, with the potential for extended clinic waiting times and unmet needs for information and psychosocial support on the part of patients and families. There is increasing interest in the most appropriate mode of follow-up for patients with lung cancer who are under observation, many of whom have completed specific treatments. Such patients may benefit from specialist nurse review for symptom control and psychosocial support. Nurse-led clinics are safe and cost effective in the oncology and research-funded setting. This study aimed to assess the acceptability of nurse-led follow-up in a large general lung cancer clinic seeing approximately 250 new patients annually. Over a 34-week period, there were 487 follow-up attendances and 94 (19.3%) of these were made by 72 patients deemed eligible for nurse-led follow-up. Sixty patients were approached and 54 (90%) agreed to participate in the study. A questionnaire containing vignette scenarios of nurse-led, telephone, GP-led, and standard (hospital, medical) follow-up was completed by 34/54 (63%) of eligible patients, 10/20 (50%) carers, 20/31 (65%) staff, and 11/38 (29%) GPs. Respondents rated acceptability of the scenarios on a range of issues on a scale of 1 to 5. Patients also completed the EORTC QLQ C30 and lung module questionnaire. Subsequent interviews were carried out with samples of these respondent groups.Fatigue, dyspnea, cough, and pain were the most common general symptoms. Both standard and nurse-led follow-up scenarios were highly rated by patients and other respondents and both were highly significantly favored over GP follow-up, which was the least favored in all areas of the questionnaire. Telephone follow-up tended to elicit more polarized reactions, both positive and negative. In interviews, in relation to nurse-led follow-up, the importance of clear protocols, training, and easy access to medical review were highlighted.

Entities:  

Mesh:

Year:  2006        PMID: 16783116     DOI: 10.1097/00002820-200605000-00003

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  14 in total

Review 1.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 2.  Optimizing cancer care through mobile health.

Authors:  Bassel Odeh; Reem Kayyali; Shereen Nabhani-Gebara; Nada Philip
Journal:  Support Care Cancer       Date:  2015-02-04       Impact factor: 3.603

Review 3.  Patients' and healthcare professionals' views of cancer follow-up: systematic review.

Authors:  Ruth A Lewis; Richard D Neal; Maggie Hendry; Barbara France; Nefyn H Williams; Daphne Russell; Dyfrig A Hughes; Ian Russell; Nicholas S A Stuart; David Weller; Clare Wilkinson
Journal:  Br J Gen Pract       Date:  2009-07       Impact factor: 5.386

Review 4.  Follow-up of cancer in primary care versus secondary care: systematic review.

Authors:  Ruth A Lewis; Richard D Neal; Nefyn H Williams; Barbara France; Maggie Hendry; Daphne Russell; Dyfrig A Hughes; Ian Russell; Nicholas S A Stuart; David Weller; Clare Wilkinson
Journal:  Br J Gen Pract       Date:  2009-07       Impact factor: 5.386

5.  The end-of-treatment telephone response and prognosis of post-radiotherapy nasopharyngeal carcinoma patients in southern China.

Authors:  Mu-Yao Chen; Yu-Shan Chen; Li-Jing Hu; Xue-Ping Lun; Dan-Dan He; Pei-Fen Chen; Lian-Ying Hu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial.

Authors:  P Murchie; M C Nicolson; P C Hannaford; E A Raja; A J Lee; N C Campbell
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

7.  Follow-up care for cancer survivors: views of the younger adult.

Authors:  K Absolom; C Eiser; G Michel; S J Walters; B W Hancock; R E Coleman; J A Snowden; D M Greenfield
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

8.  Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program.

Authors:  James Huang; Amy E Logue; Jamie S Ostroff; Bernard J Park; Mary McCabe; David R Jones; Manjit S Bains; Nabil P Rizk; Mark G Kris; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2014-07-31       Impact factor: 4.330

9.  GP-led melanoma follow-up: views and feelings of patient recipients.

Authors:  Peter Murchie; Elizabeth K Delaney; Neil C Campbell; Philip C Hannaford
Journal:  Support Care Cancer       Date:  2009-05-10       Impact factor: 3.603

10.  Nurse-led follow-up care for head and neck cancer patients: a quasi-experimental prospective trial.

Authors:  Jacqueline de Leeuw; Judith B Prins; Steven Teerenstra; Matthias A W Merkx; Henri A M Marres; Theo van Achterberg
Journal:  Support Care Cancer       Date:  2012-08-04       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.